Baohui Han
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 154
- Lung Cancer Diagnosis and Treatment 90
- Gastric Cancer Management and Outcomes 18
- Oncology 186
- Lung Cancer Research Studies 110
- Cancer Immunotherapy and Biomarkers 37
- Colorectal Cancer Treatments and Studies 17
- Co-authors
- Yanwei Zhang (66 shared papers)Liyan Jiang (18 shared papers)Runbo Zhong (55 shared papers)Hua Zhong (45 shared papers)Jianlin Xu (60 shared papers)Yizhuo Zhao (13 shared papers)Yuqing Lou (63 shared papers)Jiayuan Sun (26 shared papers)
- Journals
- Journal of Thoracic Oncology (40 papers)Annals of Oncology (31 papers)Lung Cancer (20 papers)Oncotarget (13 papers)Frontiers in Oncology (12 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Baohui Han
441 papers receiving 11.8k citations
Baohui Han's Hit Papers
Peers
Comparison fields: 5 of 148
- Oncology 4.8k
- Pulmonary and Respiratory Medicine 4.8k
- Cancer Research 1.4k
- Immunology 924
- Molecular Biology 2.3k
Countries citing papers authored by Baohui Han
This map shows the geographic impact of Baohui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baohui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baohui Han more than expected).
Fields of papers citing papers by Baohui Han
This network shows the impact of papers produced by Baohui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baohui Han. The network helps show where Baohui Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Baohui Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 451 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2018 | 503 |
| 2 | Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis Hit paper breakdown → | 2009 | 487 |
| 3 | 2011 | 323 | |
| 4 | 2017 | 317 | |
| 5 | BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 311 |
| 6 | Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11) Hit paper breakdown → | 2020 | 306 |
| 7 | 2017 | 271 | |
| 8 | 2018 | 209 | |
| 9 | 2020 | 203 | |
| 10 | 2012 | 195 | |
| 11 | Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC Hit paper breakdown → | 2021 | 191 |
| 12 | 2016 | 166 | |
| 13 | 2020 | 163 | |
| 14 | 2016 | 150 | |
| 15 | 2006 | 139 | |
| 16 | First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC Hit paper breakdown → | 2023 | 139 |
| 17 | 2012 | 125 | |
| 18 | 2017 | 125 | |
| 19 | 2016 | 120 | |
| 20 | 2021 | 119 |
About Baohui Han
Baohui Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 451 papers that have together received 12.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (154 papers), Lung Cancer Research Studies (110 papers), Lung Cancer Diagnosis and Treatment (90 papers), Cancer Immunotherapy and Biomarkers (37 papers), Cancer Genomics and Diagnostics (29 papers), RNA modifications and cancer (24 papers), Gastric Cancer Management and Outcomes (18 papers) and Colorectal Cancer Treatments and Studies (17 papers). The work is most often cited by research in Oncology (4.8k citations), Pulmonary and Respiratory Medicine (4.8k citations), Cancer Research (1.4k citations), Immunology (924 citations) and Molecular Biology (2.3k citations). Baohui Han has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yanwei Zhang, Liyan Jiang, Runbo Zhong, Hua Zhong, Jianlin Xu, Yizhuo Zhao, Yuqing Lou, Jiayuan Sun, Wei Dong Zhang and Jiajun Teng. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer, Oncotarget and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.